Par-4 for Molecular Therapy of Prostate Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|4|3|223-230

ISSN： 1389-4501

Source： Current Drug Targets, Vol.4, Iss.3, 2003-04, pp. : 223-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Therapy Intervention Prospects in Prostate Cancer

By  

Current Pharmaceutical Design, Vol. 10, Iss. 5, 2004-02 ,pp. : 523-530

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Foundations for Personalized Therapy in Prostate Cancer

By  

Current Drug Targets, Vol. 16, Iss. 2, 2015-02 ,pp. : 103-114

Bentham Science Publishers

Access to resources Recommend Favorite

Par-4 as a potential target for cancer therapy

By Irby Rosalyn B   Kline Christina LB  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 77-87

Informa Healthcare

Access to resources Recommend Favorite

Integrated, Molecular Engineering Approaches to Develop Prostate Cancer Gene Therapy

By  

Current Gene Therapy, Vol. 3, Iss. 5, 2003-10 ,pp. : 452-467

Bentham Science Publishers

Access to resources Recommend Favorite

PAR-4 as a possible new target for pancreatic cancer therapy

By Azmi Asfar S   Philip Philip A   Zafar Syed F   Sarkar Fazlul H   Mohammad Ramzi M  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 611-620

Informa Healthcare

Access to resources Recommend Favorite